The cell therapy technologies market is estimated to reach USD 7.8 billion by 2028 from USD 4.2 billion in 2023, at a CAGR of 13.3% during the forecast period. Increased use of cell therapy technologies for various research coupled with increased research funding are some of the major factors driving the growth of the market.
The prominent players operating in the cell therapy technologies market include Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Danaher Corporation (US), Becton, Dickinson, and Company (US), Lonza Group (Switzerland), Sartorius AG (Germany) and among others.
To know about the assumptions considered for the study download the pdf brochure
Thermo Fisher Scientific, Inc. (US)
Thermo Fisher Scientific is a leading science and technology company engaged in manufacturing analytical instruments, laboratory equipment, software, consumables, reagents, and services for scientific research, analysis, discovery, and diagnostics. The company operates through four business segments such as life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services. Thermo Fisher offers products in the cell therapy technologies market through its life sciences solutions segment.
Merck KGaA (Germany)
Merck KGAA is a leading science and technology company engaged in manufacturing and providing different products for pharma, healthcare and electronic technology industries. The company operates through three business segments, namely, life science, healthcare, and electronics. The healthcare segment includes process solutions, life science services, science & lab solutions. The life science segment offers life science products and services for research and diagnostic purposes. Company offers products in the cell therapy technologies market through the life science segment. The company is operates in over 70 countries across North America, South America, Latin America, Europe, Asia, Africa, and the Middle East.
Cell Therapy Technologies Market by Product (Media, Sera & Reagents, Cell Culture Vessels, Single-Use Equipment), Process (Cell Processing, Preservation), Cell type (T-Cells, Stem cells), End User (Biopharma, CROs, CMOs), Region - Global Forecast to 2028
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.SEND ME A FREE SAMPLE